Lymphoma Research Foundation is located in New York, NY. The organization was established in 1996. According to its NTEE Classification (G80) the organization is classified as: Specifically Named Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2022, Lymphoma Research Foundation employed 34 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lymphoma Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Lymphoma Research Foundation generated $14.7m in total revenue. This represents relatively stable growth, over the past 5 years the organization has increased revenue by an average of 8.0% each year. All expenses for the organization totaled $12.9m during the year ending 06/2022. While expenses have increased by 8.8% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Lymphoma Research Foundation has awarded 102 individual grants totaling $11,790,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO ERADICATE LYMPHOMA AND SERVE THOSE TOUCHED BY THIS DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH AND PATIENT AID - THE FOUNDATION IS COMMITTED TO FUNDING THE MOST ADVANCE PATIENT CARE AND IMPROVE PATIENT OUTCOMES. THROUGH ITS LYMPHOMA CONSORTIA, RESEARCH INITIATIVES, AND SCIENTIFIC WORKSHOPS, LRF MOBILIZES THE RESEARCH COMMUNITY TO SPEED THE DEVELOPMENT AND USE OF NEW TREATMENTS.
EDUCATIONAL PROGRAMS AND PATIENT SERVICES - LRF PROVIDES A COMPREHENSIVE SERIES OF PROGRAMS AND SERVICES FOR THE LYMPHOMA COMMUNITY INCLUDING, BUT NOT LIMITED TO, CONTINUING MEDICAL EDUCATION, CLINICAL TRIALS INFORMATION SERVICES, DISEASE SPECIFIC PUBLICATIONS AND WEBSITES, IN-PERSON PATIENT WORKSHOPS AND EDUCATIONAL FORUMS, LYMPHOMA HELPLINE, ONLINE SERVICES, PATIENT AID GRANTS, TELECONFERENCES AND WEBCASTS/PODCASTS, WITH A VOLUNTEER COMMUNITY NETWORK.
COMMUNICATIONS AND ADVOCACY - THROUGH STRATEGIC COMMUNICATIONS, LRF SEEKS TO RAISE AWARENESS OF LYMPHOMA AND THE NEEDS OF PEOPLE WITH LYMPHOMA. DIGITAL PROGRAMMING ENSURES ACCESS TO ACCURATE INFORMATION AND DIGITAL PROGRAMS INCLUDING MOBILE APPS. LRF'S ADVOCACY PROGRAM ENABLES VOLUNTEERS TO REPRESENT THE NEEDS OF PEOPLE WITH LYMPHOMA BY SUPPORTING PUBLIC POLICIES WHICH SEEK TO INCREASE FEDERAL FUNDING FOR LYMPHOMA RESEARCH AND ENSURE ACCESS TO HIGH QUALITY CANCER CARE
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Meghan Gutierrez Chief Executive Officer | Officer | 35 | $318,291 |
Carolina Flores Senior Director Of Finance | Officer | 35 | $179,168 |
Sarah Quinlan Senior Director, Program | 35 | $164,413 | |
Kinya Harte Director, Comm. & Marketing | 35 | $130,800 | |
Victor Gonzalez Senior Director, Patient Prog. | 35 | $109,148 | |
Kathryn Leboeuf Director, Maj.& Planned Giving | 35 | $112,431 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Med Communications Inc Communications | 6/29/22 | $278,079 |
Allison Partners Llc Public Relations | 6/29/22 | $247,611 |
Build Consulting Llc It Consulting | 6/29/22 | $194,666 |
Blackbaud Software | 6/29/22 | $180,579 |
Harborside Hotel Llc Dba Hyatt Rege Venue & Catering | 6/29/22 | $193,247 |
Statement of Revenue | |
---|---|
Federated campaigns | $15,016 |
Membership dues | $0 |
Fundraising events | $1,903,845 |
Related organizations | $0 |
Government grants | $486,300 |
All other contributions, gifts, grants, and similar amounts not included above | $7,508,650 |
Noncash contributions included in lines 1a–1f | $131,511 |
Total Revenue from Contributions, Gifts, Grants & Similar | $9,913,811 |
Total Program Service Revenue | $4,596,956 |
Investment income | $153,520 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $22,595 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $945 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $14,709,927 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $4,870,000 |
Grants and other assistance to domestic individuals. | $35,500 |
Grants and other assistance to Foreign Orgs/Individuals | $855,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $513,790 |
Compensation of current officers, directors, key employees. | $66,369 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,260,446 |
Pension plan accruals and contributions | $78,822 |
Other employee benefits | $411,350 |
Payroll taxes | $306,691 |
Fees for services: Management | $0 |
Fees for services: Legal | $14,697 |
Fees for services: Accounting | $54,696 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $1,076,131 |
Advertising and promotion | $459,457 |
Office expenses | $338,198 |
Information technology | $60,021 |
Royalties | $0 |
Occupancy | $381,120 |
Travel | $188,912 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $645,701 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $65,729 |
Insurance | $31,204 |
All other expenses | -$193,398 |
Total functional expenses | $12,900,895 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $9,111,263 |
Savings and temporary cash investments | $23,159,618 |
Pledges and grants receivable | $488,721 |
Accounts receivable, net | $2,401,505 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $285,347 |
Net Land, buildings, and equipment | $99,724 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $35,546,178 |
Accounts payable and accrued expenses | $1,052,864 |
Grants payable | $6,741,890 |
Deferred revenue | $195,373 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $7,990,127 |
Net assets without donor restrictions | $5,715,532 |
Net assets with donor restrictions | $21,840,519 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $35,546,178 |
Over the last fiscal year, Lymphoma Research Foundation has awarded $4,870,000 in support to 23 organizations.
Grant Recipient | Amount |
---|---|
WASHINGTON UNIVERSITY IN STLOUIS PURPOSE: Follicular | $750,000 |
MASSACHUSETTS GENERAL HOSPITAL PURPOSE: Follicular | $750,000 |
MILLER SCHOOL OF MEDICINE OF THE UNIV0 OF MIAMI PURPOSE: CDA | $225,000 |
MEMORIAL SLOAN KETTERING CANCER CENTER PURPOSE: Follicular | $750,000 |
MAYO CLINIC PURPOSE: Follicular | $750,000 |
THE UNIVERSITY OF UTAH PURPOSE: CDA | $225,000 |